We have studied the effect of glucocorticoids administered in vivo on the activity and synthesis of the cyclooxygenase enzyme (COX) in mice treated with or without concurrent intravenous administration of LPS. Mouse peritoneal macrophages from LPS-treated animals showed a two to three fold increase in COX activity determined by the production of PGE2 and PGI2 after stimulation of the cells with exogenous arachidonate. Dexamethasone injected simultaneously with LPS, 12 h before killing of the animal and removal of the macrophages, completely blocked the LPS-induced increase COX activity in peritoneal macrophages. The regulation observed in COX activity by LPS and dexamethasone are due primarily to changes in COX mass as determined by immunoprecipitation of [35S]methionine endogenously labeled enzyme. In contrast, the COX present in the nonadherent cells and in renal medullary microsomes obtained from the same animals, showed no significant changes between treatments. These results indicate that LPS in vivo stimulates COX synthesis in the peritoneal macrophages but not in the kidney. The effect of dexamethasone to inhibit COX synthesis is selective to the LPS-induced enzyme.
J L Masferrer, B S Zweifel, K Seibert, P Needleman
Year: | 2025 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1985 | 1984 | 1981 | 1976 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 5 | 1 | 4 | 4 | 3 | 4 | 4 | 3 | 5 | 6 | 8 | 9 | 8 | 8 | 10 | 9 | 13 | 21 | 22 | 19 | 20 | 20 | 16 | 17 | 10 | 19 | 5 | 1 | 1 | 2 | 2 | 290 |
Title and authors | Publication | Year |
---|---|---|
Exploring the potential link between human papillomavirus infection and coronary artery disease: a review of shared pathways and mechanisms.
Saha D, Dutta P, Rebello KR, Shankar A, Chakraborty A |
Molecular and cellular biochemistry | 2025 |
Effects of Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Gastroprotective NSAIDs on the Gastrointestinal Tract: A Narrative Review.
Sohail R, Mathew M, Patel KK, Reddy SA, Haider Z, Naria M, Habib A, Abdin ZU, Razzaq Chaudhry W, Akbar A |
Cureus | 2023 |
Acetylsalicylic Acid Is Associated With a Lower Prevalence of Ascending Aortic Aneurysm and a Decreased Aortic Expression of Cyclooxygenase 2.
Granath C, Freiholtz D, Bredin F, Olsson C, Franco-Cereceda A, Björck HM |
Journal of the American Heart Association | 2022 |
Biochemistry of Drug Resistance
S Ahmed, SC Ojha, M Najam-ul-Haq, M Younus, MZ Hashmi |
2021 | |
Co-delivery of Dexamethasone and a MicroRNA-155 Inhibitor Using Dendrimer-Entrapped Gold Nanoparticles for Acute Lung Injury Therapy
C Li, J Li, Y Fan, D Wang, M Zhan, M Shen, X Shi |
Biomacromolecules | 2021 |
Control of immunity by glucocorticoids in health and disease
A Shimba, K Ikuta |
Seminars in Immunopathology | 2020 |
Application of per-residue energy decomposition to identify the set of amino acids critical for in silico prediction of COX-2 inhibitory activity
N Chaudhary, P Aparoy |
Heliyon | 2020 |
Murrayanine Attenuates Lipopolysaccharide-induced Inflammation and Protects Mice from Sepsis-associated Organ Failure
S Gupta, V Khajuria, A wani, Y Nalli, A Bhagat, A Ali, Z Ahmed |
Basic & Clinical Pharmacology & Toxicology | 2019 |
Nijkamp and Parnham's Principles of Immunopharmacology
MJ Parnham, FP Nijkamp, AG Rossi |
2019 | |
Molecular docking, molecular modeling, and molecular dynamics studies of azaisoflavone as dual COX-2 inhibitors and TP receptor antagonists
M Hadianawala, AD Mahapatra, JK Yadav, B Datta |
Journal of Molecular Modeling | 2018 |
Preparation and functionalization of acetylsalicylic acid loaded chitosan/gelatin membranes from ethanol-based suspensions via electrophoretic deposition
F Wang, P Huang, D Huang, Y Hu, K Ma, X Cai, T Jiang |
Journal of Materials Chemistry B | 2018 |
Kelley and Firestein's Textbook of Rheumatology
PE di Cesare, DR Haudenschild, J Samuels, SB Abramson |
Kelley and Firestein's Textbook of Rheumatology | 2017 |
Bergapten prevents lipopolysaccharide-induced inflammation in RAW264.7 cells through suppressing JAK/STAT activation and ROS production and increases the survival rate of mice after LPS challenge
Y Zhou, J Wang, W Yang, X Qi, L Lan, L Luo, Z Yin |
International Immunopharmacology | 2017 |
Involvement of Arachidonic Acid Metabolites Pathway and Nicotinic Acetylcholine Receptors (nAChRs) on Nicotine-induced Contractions (or Relaxations) in the Basilar Artery
Y Li, D Luo, X Chen, J Li, L Yan, T Li, Y Zhao, H Liu, X Ji, X Ma |
International Journal of Pharmacology | 2017 |
The amino analogue of β-boswellic acid efficiently attenuates the release of pro-inflammatory mediators than its parent compound through the suppression of NF-κB/IκBα signalling axis
S Gupta, AU Ahsan, A Wani, V Khajuria, LA Nazir, S Sharma, A Bhagat, PR Sharma, S Bhardwaj, KJ Peerzada, BA Shah, Z Ahmed |
Cytokine | 2017 |
Attenuation of nociceptive pain and inflammatory disorders by total steroid and terpenoid fraction of Euphorbia tirucalli Linn root in experimental in vitro and in vivo model
P Palit, D Mukherjee, P Mahanta, Shadab, N Ali, S Roychoudhury, Asad, SC Mandal |
Inflammopharmacology | 2017 |
Deciphering the mechanism behind the varied binding activities of COXIBs through Molecular Dynamic Simulations, MM-PBSA binding energy calculations and per-residue energy decomposition studies
N Chaudhary, P Aparoy |
Journal of Biomolecular Structure and Dynamics | 2016 |
Prostanoids and NSAIDs in Cardiovascular Biology and Disease
BB Weksler |
Current Atherosclerosis Reports | 2015 |
Effect of Curcumin in Experimental Peritonitis
S D, I Mani, G Ravikumar, ST Avadhany |
Indian Journal of Surgery | 2015 |
Cyclooxygenase I and II inhibitors distinctly enhance hippocampal- and cortex-dependent cognitive functions in mice
H Syed, M Ikram, A Yaqinuddin, T Ahmed |
Molecular medicine reports | 2015 |
Drug-Device Combinations For Chronic Diseases
MN Avula, DW Grainger |
Drug-Device Combinations For Chronic Diseases | 2015 |
Late Postoperative Hemorrhage in a Patient With Undiagnosed COX-1 Deficiency After Third Molar Extractions
JC Doscher, FN Volpe |
Journal of Oral and Maxillofacial Surgery | 2014 |
Effects of Danshensu on Platelet Aggregation and Thrombosis: In Vivo Arteriovenous Shunt and Venous Thrombosis Models in Rats
C Yu, D Qi, W Lian, QZ Li, HJ Li, HY Fan, PG de Frutos |
PloS one | 2014 |
First report of interruption of mast cell degranulation and endothelial cells activation by anti-inflammatory drugs controlling the acute response provoked by Pseudoplatystoma fasciatum fish venom
M Lopes-Ferreira, EM Gomes, FM Bruni, MJ Ferreira, P Charvet, C Lima |
Toxicon | 2014 |
Synthesis of Some Novel Benzoxazolinonylcarboxamides as Potential Anti-Inflammatory Agents
L Messaoud, Y Wassila, S Khemissi, A Yasmina, C Hanane |
Journal of Chemical Research | 2014 |
Evaluation of the effect of kaempferol in a murine allergic rhinitis model
HA Oh, NR Han, MJ Kim, HM Kim, HJ Jeong |
European Journal of Pharmacology | 2013 |
Enzyme Technologies: Pluripotent Players in Discovering Therapeutic Agents
T Ohshiro, H Tomoda |
Enzyme Technologies: Pluripotent Players in Discovering Therapeutic Agents | 2013 |
Anti-inflammatory and antioxidative effects of the methanolic extract of the aerial parts of M itracarpus frigidus in established animal models: Biological effects of Mitracarpus frigidus
RL Fabri, RA Garcia, JR Florêncio, NC Pinto, LG de Oliveira, JA Aguiar, A Ribeiro, E Scio |
Journal of Pharmacy and Pharmacology | 2013 |
COX inhibitors for airway inflammation
S Malhotra, SS Deshmukh, SG Dastidar |
Expert Opinion on Therapeutic Targets | 2012 |
Therapeutic Potential of Small Molecules Modulating the Cyclooxygenase-5-Lipoxygenase Pathway
W Albrecht, S Laufer |
Polypharmacology in Drug Discovery Peters/Polypharmacology | 2012 |
Description of 3 Cases in Vietnam of Aspirin Desensitization in Patients With Coronary Artery Disease and Coexisting Aspirin Hypersensitivity:
DV Nguyen, HC Chi, DV Nguyen, TJ Craig, S Nunen |
World Allergy Organization Journal | 2012 |
Clinical Use of Aspirin in Treatment and Prevention of Cardiovascular Disease
Y Dai, J Ge |
Thrombosis | 2012 |
Annual Reports in Medicinal Chemistry
JJ Liu, TW Lee |
Annual Reports in Medicinal Chemistry Volume 46 | 2011 |
Influence of Experimental Subarachnoid Hemorrhage on Nicotine-induced Contraction of the Rat Basilar Artery in Relation to Arachidonic Acid Metabolites Signaling Pathway
X Ji, A Wang, CC Trandafir, K Kurahashi |
Journal of Stroke and Cerebrovascular Diseases | 2011 |
Principles of Immunopharmacology
FP Nijkamp, MJ Parnham |
2011 | |
Pharmakotherapie in der Anästhesie und Intensivmedizin
PH Tonner, L Hein |
2011 | |
Parecoxib sodium in the treatment of postoperative pain after Lichtenstein tension-free mesh inguinal hernia repair
AV Kyriakidis, I Perysinakis, I Alexandris, K Athanasiou, C Papadopoulos, I Mpesikos |
Hernia | 2010 |
Does administration of non-steroidal anti-inflammatory drug determine morphological changes in adrenal cortex: ultrastructural studies
W Matysiak, B Jodłowska-Jedrych |
Protoplasma | 2010 |
Cyclooxygenase-2 Expression in Animal Cancers
M Doré |
Veterinary pathology | 2010 |
Nippon Jibiinkoka Gakkai Kaiho
N Inagaki |
Nippon Jibiinkoka Gakkai Kaiho | 2009 |
Resident peritoneal macrophages and mast cells are important cellular sites of COX-1 and COX-2 activity during acute peritoneal inflammation
E Kolaczkowska, A Goldys, E Kozakiewicz, M Lelito, B Plytycz, N Rooijen, B Arnold |
Archivum Immunologiae et Therapiae Experimentalis | 2009 |
Inhibition of iNOS and COX-2 in human whole blood ex vivo and monocyte-macrophage J774 cells by a new group of aminothiopyrimidone derivatives
V Cardile, L Lombardo, G Granata, A Perdicaro, M Balazy, A Santagati |
Bioorganic & Medicinal Chemistry | 2009 |
Nonsteroidal Anti-Inflammatory Drugs and Coxibs
TK Kvien |
Rheumatoid Arthritis | 2009 |
Kelley's Textbook of Rheumatology
J Degroot, AM Zuurmond, PP Tak |
Kelley's Textbook of Rheumatology | 2009 |
Cyclooxygenase products and atherosclerosis
MF Linton, S Fazio |
Drug discovery today. Therapeutic strategies | 2008 |
Celecoxib and ankylosing spondylitis
A Calin |
Expert Review of Clinical Immunology | 2008 |
Acute salivary gland hypofunction in the duct ligation model in the absence of inflammation
PN Correia, GH Carpenter, SM Osailan, KL Paterson, GB Proctor |
Oral Diseases | 2008 |
Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs
JG Wooten, AT Blikslager, KA Ryan, SL Marks, JM Law, BD Lascelles |
American Journal of Veterinary Research | 2008 |
In vivo and in vitro metabolism of lefucoxib in rats
X Bi, Z Meng, H Chen, X Zhu, G Dou |
Journal of Pharmaceutical and Biomedical Analysis | 2008 |
Possible role of cyclooxygenase-2 inhibitors as anticancer agents
S Boonsoda, P Wanikiat |
Veterinary Record | 2008 |
Effect of the COX-2 Inhibitor Celecoxib on Behavioural and Immune Changes in an Olfactory Bulbectomised Rat Model of Depression
AM Myint, HW Steinbusch, L Goeghegan, D Luchtman, YK Kim, BE Leonard |
Neuroimmunomodulation | 2007 |
Cyclooxygenase-1 inhibition delays recovery of the cutaneous barrier disruption caused by mechanical scratching in mice
Y Honma, I Arai, N Futaki, Y Hashimoto, M Sugimoto, T Sakurai, S Nakaike |
British Journal of Dermatology | 2007 |
Alternative splicing of cyclooxygenase-1 gene: altered expression in leucocytes from patients with bronchial asthma and association with aspirin-induced 15-HETE release
ML Kowalski, M Borowiec, M Kurowski, R Pawliczak |
Allergy | 2007 |
Drug Insight: cyclo-oxygenase-2 inhibitors—a critical appraisal
B Hinz, B Renner, K Brune |
Nature Clinical Practice Rheumatology | 2007 |
Therapeutic hypothermia in acute ischemic stroke
H Hertog, B der Worp, M Gemert, D Dippel |
Expert Review of Neurotherapeutics | 2007 |
Clinical pharmacology of celecoxib, a COX-2 selective inhibitor
K Antoniou, M Malamas, AA Drosos |
Expert Opinion on Pharmacotherapy | 2007 |
Handbook of Systemic Autoimmune Diseases
M Karmegam, RJ Quigg |
Handbook of Systemic Autoimmune Diseases | 2007 |
Pharmacological nature of nicotine-induced contraction in the rat basilar artery: Involvement of arachidonic acid metabolites
X Ji, T Nishihashi, CC Trandafir, A Wang, Y Shimizu, K Kurahashi |
European Journal of Pharmacology | 2007 |
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
T Grosser, S Fries, GA FitzGerald |
Journal of Clinical Investigation | 2006 |
Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism
GM Borthwick, AS Johnson, M Partington, J Burn, R Wilson, HM Arthur |
The FASEB Journal | 2006 |
Prostaglandins in Health and Disease: An Overview
SB Miller |
Seminars in Arthritis and Rheumatism | 2006 |
COX-1 inhibition enhances scratching behaviour in NC/Nga mice with atopic dermatitis
M Sugimoto, I Arai, N Futaki, Y Hashimoto, Y Honma, S Nakaike |
Experimental Dermatology | 2006 |
Update on COX-2 inhibitor patents with a focus on optimised formulation and therapeutic scope of drug combinations making use of COX-2 inhibitors
U Puhlmann, D Schäfer, C Ziemann |
Expert Opinion on Therapeutic Patents | 2006 |
Effect of COX-2 inhibitors and non-steroidal anti-inflammatory drugs on a mouse fracture model
BH Mullis, ST Copland, PS Weinhold, T Miclau, GE Lester, GD Bos |
Injury | 2006 |
Cyclooxygenase: Past, present and future. A tribute to John R. Vane (1927–2004)
RM Botting |
Journal of Thermal Biology | 2006 |
Inhibition of prostaglandins does not reduce the cardiovascular changes during endotoxemia in rats
A Azab, S Kobal, M Rubin, J Kaplanski |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 2006 |
Analgesia
C Stein |
Analgesia | 2006 |
Comparative Effects of Indomethacin and Nabumetone on Urine and Electrolyte Output in Conscious Rats
I Long, HJ Singh, GJ Rao |
Journal of Pharmacological Sciences | 2005 |
Development and validation of a new model of inflammation in the cat and selection of surrogate endpoints for testing anti-inflammatory drugs
JM Giraudel, A Diquelou, P Lees, PL Toutain |
Journal of Veterinary Pharmacology and Therapeutics | 2005 |
Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing
BM Peskar |
InflammoPharmacology | 2005 |
Cyclooxygenase inhibition attenuates endotoxin-induced spatial learning deficits, but not an endotoxin-induced blockade of long-term potentiation
KN Shaw, S Commins, SM O'Mara |
Brain Research | 2005 |
Neuronal prostaglandin endoperoxide synthase 2 responses to oxygen and glucose deprivation are mediated by mitogen-activated protein kinase ERK1/2
D Zhang, CE Wood |
Brain Research | 2005 |
Clinical implications of cyclo-oxygenase–2 inhibitors for acute dental pain management
M Spink, S Bahn, R Glickman |
The Journal of the American Dental Association | 2005 |
COX-2: A Molecular Target for Colorectal Cancer Prevention
JR Brown, RN DuBois |
Journal of Clinical Oncology | 2005 |
Role of cyclooxygenase isoforms in gastric mucosal defense and ulcer healing
BM Peskar |
Inflammopharmacology | 2005 |
Effects of Nimesulide, a Selective Cyclooxygenase-2 Inhibitor, on Cardiovascular Alterations in Endotoxemia
AN Azab, S Kobal, M Rubin, J Kaplanski |
Cardiology | 2004 |
The discovery and development of antiinflammatory drugs
K Brune, B Hinz |
Arthritis & Rheumatism | 2004 |
The cyclooxygenase isozyme inhibitors parecoxib and paracetamol reduce central hyperalgesia in humans
W Koppert, A Wehrfritz, N Körber, R Sittl, S Albrecht, J Schüttler, M Schmelz |
PAIN | 2004 |
El ácido acetilsalicílico incrementa la expresión de CD36 en macrófagos THP-1 de forma independiente del receptor activado por proliferadores peroxisómicos gamma
M Viñals, I Bermúdez, JC Laguna |
Clínica e Investigación en Arteriosclerosis | 2004 |
Involvement of eicosanoids in the hypothermic response to lipopolysaccharide during endotoxemia in rats
AN Azab, J Kaplanski |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 2004 |
Ischaemia–Reperfusion Injury in the Isolated Haemoperfused Bovine Uterus: An In Vitro Model of Acute Inflammation
M Braun, M Kietzmann |
Alternatives to laboratory animals : ATLA | 2004 |
COX-2 Inhibitors
M Pairet, J van Ryn |
2004 | |
Nabumetone: Therapeutic Use and Safety Profile in the Management of Osteoarthritis and Rheumatoid Arthritis
T Hedner, O Samulesson, P Whrborg, H Wadenvik, KA Ung, A Ekbom |
Drugs | 2004 |
Cyclooxygenase-1-Coupled Prostaglandin Biosynthesis Constitutes an Essential Prerequisite for Skin Repair
H Kämpfer, L Bräutigam, G Geisslinger, J Pfeilschifter, S Frank |
Journal of Investigative Dermatology | 2003 |
Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa
S Fiorucci, L Santucci, JL Wallace, M Sardina, M Romano, P Soldato, A Morelli |
Proceedings of the National Academy of Sciences | 2003 |
Unexpected Nanomolar Inhibition of Carbonic Anhydrase by COX-2-Selective Celecoxib: New Pharmacological Opportunities Due to Related Binding Site Recognition
A Weber, A Casini, A Heine, D Kuhn, CT Supuran, A Scozzafava, G Klebe |
Journal of Medicinal Chemistry | 2003 |
Selective Cyclooxygenase-2 Inhibition: A Target in Cancer Prevention and Treatment
S Subongkot, D Frame, W Leslie, D Drajer |
Pharmacotherapy | 2003 |
The Combined Effect of Topical CX-659S, a Novel Diaminouracil Derivative, With Topical Corticosteroid on the Three Types of Allergic Responses in Mice or Guinea Pigs
Y Inoue, M Isobe, H Hayashi |
Journal of Pharmacological Sciences | 2003 |
The development of COX2 inhibitors
RJ Flower |
Nature Reviews Drug Discovery | 2003 |
Advances in Modelling and Clinical Application of Intravenous Anaesthesia
J Vuyk, S Schraag |
2003 | |
The Second Generation of COX-2 Inhibitors: What Advantages Do the Newest Offer?
DO Stichtenoth, JC Frlich |
Drugs | 2003 |
Persistence of Mucosal Mast Cells and Eosinophils in Shigella -Infected Children
R Raqib, PK Moly, P Sarker, F Qadri, NH Alam, M Mathan, J Andersson |
Infection and immunity | 2003 |
Cyclooxygenase (COX) Inhibitors: A Comparative QSAR Study
R Garg, A Kurup, SB Mekapati, C Hansch |
Chemical Reviews | 2003 |
Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice
ME Burleigh, VR Babaev, JA Oates, RC Harris, S Gautam, D Riendeau, LJ Marnett, JD Morrow, S Fazio, MR Linton |
Circulation | 2002 |
Osteoarthritis IV: Clinical therapeutic trials and treatment
WW Buchanan, WF Kean |
InflammoPharmacology | 2002 |
Cyclooxygenase-2 inhibitors: promise or peril?
LJ Mengle-Gaw, BD Schwartz |
Mediators of Inflammation | 2002 |
The adverse renal effects of prostaglandin-synthesis inhibition in the fetus and the newborn
A Drukker |
Paediatrics & child health | 2002 |
Design of peptides and peptidomimetics as COX-2 selective inhibitors
V Kothekar, S Sahi |
Journal of Molecular Structure: THEOCHEM | 2002 |
Cyclooxygenase-2 Expression in Cultured Cortical Thick Ascending Limb of Henle Increases in Response to Decreased Extracellular Ionic Content by Both Transcriptional and Post-transcriptional Mechanisms: ROLE OF p38-MEDIATED PATHWAYS
HF Cheng, RC Harris |
The Journal of biological chemistry | 2002 |
Prostaglandins that increase renin production in response to ACE inhibition are not derived from cyclooxygenase-1
HF Cheng, SW Wang, MZ Zhang, JA McKanna, R Breyer, RC Harris |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2002 |
N-3 and n-6 fatty acids stimulate restitution by independent mechanisms in the IEC-6 model of intestinal wound healing
DJ Ruthig, KA Meckling-Gill |
The Journal of Nutritional Biochemistry | 2002 |
Disposition of a Specific Cyclooxygenase-2 Inhibitor, Valdecoxib, in Human
JJ Yuan, D Yang, JY Zhang, R Bible, A Karim, JW Findlay |
Drug Metabolism and Disposition | 2002 |
Cyclooxygenase 2 and the kidney
MD Breyer, RC Harris |
Current Opinion in Nephrology and Hypertension | 2001 |
COX-2???Specific Inhibitors: Definition of a New Therapeutic Concept
KM Verburg, TJ Maziasz, E Weiner, L Loose, GS Geis, PC Isakson |
American Journal of Therapeutics | 2001 |
Drugs for the Treatment of Allergic Diseases
N Inagaki, H Nagai |
The Japanese Journal of Pharmacology | 2001 |
Guest Editorial: The Use of COX-2-Specific Inhibitors: Is It All Hype or Is It Evidence Based?
A Ince |
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences | 2001 |
The ‘in vivo’ and ‘ex vivo’ roles of cylcooxygenase-2, nuclear factor-κB and protein kinases pathways in the up-regulation of B1 receptor-mediated contraction of the rabbit aorta
R Medeiros, DA Cabrini, JB Calixto |
Regulatory Peptides | 2001 |
Induction of cyclooxygenase-2 in thick ascending limb cells by adrenalectomy
CP Vio, SJ An, C Céspedes, JC McGiff, NR Ferreri |
Journal of the American Society of Nephrology : JASN | 2001 |
Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury
S Cuzzocrea, RJ Reiter |
European Journal of Pharmacology | 2001 |
A perfusion technique for the determination of pro-inflammatory mediators induced by intradental application of irritants
JJ Chidiac, N Hawwa, M Baliki, B Safieh-Garabedian, K Rifai, SJ Jabbur, NE Saadé |
Journal of Pharmacological and Toxicological Methods | 2001 |
Physiological regulation of cyclooxygenase-2 in the kidney
RC Harris, MD Breyer |
American journal of physiology. Renal physiology | 2001 |
Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis
JL Goldstein, P Correa, WW Zhao, AM Burr, RC Hubbard, KM Verburg, GS Geis |
The American Journal of Gastroenterology | 2001 |
Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries
JK Hennan, J Huang, TD Barrett, EM Driscoll, DE Willens, AM Park, LJ Crofford, BR Lucchesi |
Circulation | 2001 |
Advances in Prostaglandin and Leukotriene Research
B Samuelsson, R Paoletti, GC Folco, E Granström, S Nicosia |
2001 | |
Cancer Pain: Assessment and Management
ED Bruera, RK Portenoy |
2001 | |
Regulated expression of both cyclooxygenase (COX) isoforms in a human model of inflammation: effects on generation of eicosanoids and isoeicosanoids in vivo
B.F. McAdam, I.A. Mardini, A. Habib, A. Burke, J.A. Lawson, S. Kapoor, G.A. FitzGerald |
Journal of Clinical Investigation | 2000 |
The Microcirculation and Inflammation: Site of Action for Glucocorticoids
M Perretti, A Ahluwalia |
Microcirculation | 2000 |
COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease
DA Willoughby, AR Moore, PR Colville-Nash |
The Lancet | 2000 |
Non-steroidal anti-inflammatory drug toxicity in the upper gastrointestinal tract
J Sung, R Russell, N Yeomans, F Chan, S Chen, K Fock, K Goh, P Kullavanijaya, K Kimura, C Lau, J Louw, J Sollano, G Triadiafalopulos, S Xiao, P Brooks |
Journal of Gastroenterology and Hepatology | 2000 |
Naturally occurring antinociceptive substances from plants
JB Calixto, A Beirith, J Ferreira, AR Santos, VC Filho, RA Yunes |
Phytotherapy Research | 2000 |
Basic biology and clinical application of specific cyclooxygenase-2 inhibitors
LJ Crofford, PE Lipsky, P Brooks, SB Abramson, LS Simon, LB van de Putte |
Arthritis & Rheumatism | 2000 |
New insights into physiological and pathophysiological functions of cyclo-oxygenase-2
B Hinz, K Brune |
Current Opinion in Anaesthesiology | 2000 |
Inhibitors of cyclooxygenase-2: November 1999 - April 2000
JS Carter |
Expert Opinion on Therapeutic Patents | 2000 |
Selective cyclooxygenase-2 (COX-2) inhibitors reduce anti-Mycobacterium antibodies in adjuvant arthritic rats
À Turull, J Queralt |
Immunopharmacology | 2000 |
Physiologic characteristics and clinical importance of the cyclooxygenase isoforms in dogs and cats
CJ Jones, SC Budsberg |
Journal of the American Veterinary Medical Association | 2000 |
Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs
J Steinmeyer |
Arthritis research | 2000 |
Aspirin and other anti-inflammatory drugs
SJ Vane |
Thorax | 2000 |
Annexin I and dexamethasone effects on phospholipase and cyclooxygenase activity in human synoviocytes
AV Sampey, P Hutchinson, EF Morand |
Mediators of Inflammation | 2000 |
DIAGNOSIS AND TREATMENT OF NONSTEROIDAL ANTI-INFLAMMATORY DRUG-ASSOCIATED UPPER GASTROINTESTINAL TOXICITY
MS Cappell, JR Schein |
Gastroenterology Clinics of North America | 2000 |
The “Aspirin” of the New Millennium: Cyclooxygenase-2 Inhibitors
NS Buttar, KK Wang |
Mayo Clinic Proceedings | 2000 |
Localization and regulation of cyclo-oxygenase-1 and -2 and neuronal nitric oxide synthase in mouse spinal cord
C Maihöfner, I Tegeder, C Euchenhofer, D deWitt, K Brune, R Bang, W Neuhuber, G Geisslinger |
Neuroscience | 2000 |
Spatial Requirements for 15-( R )-Hydroxy-5 Z ,8 Z ,11 Z ,13 E -eicosatetraenoic Acid Synthesis within the Cyclooxygenase Active Site of Murine COX-2: WHY ACETYLATED COX-1 DOES NOT SYNTHESIZE 15-(R)-HETE
SW Rowlinson, BC Crews, DC Goodwin, C Schneider, JK Gierse, LJ Marnett |
The Journal of biological chemistry | 2000 |
Advances in Eicosanoid Research
CN Serhan, HD Perez |
2000 | |
Cyclooxygenase-2 in the Kidney
RC Harris |
Journal of the American Society of Nephrology : JASN | 2000 |
Selective Cyclooxygenase-2 Inhibitors: Heteroaryl Modified 1,2-Diarylimidazoles Are Potent, Orally Active Antiinflammatory Agents
IK Khanna, Y Yu, RM Huff, RM Weier, X Xu, FJ Koszyk, PW Collins, JN Cogburn, PC Isakson, CM Koboldt, JL Masferrer, WE Perkins, K Seibert, AW Veenhuizen, J Yuan, DC Yang, YY Zhang |
Journal of Medicinal Chemistry | 2000 |
4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, Valdecoxib: A Potent and Selective Inhibitor of COX-2
JJ Talley, DL Brown, JS Carter, MJ Graneto, CM Koboldt, JL Masferrer, WE Perkins, RS Rogers, AF Shaffer, YY Zhang, BS Zweifel, K Seibert |
Journal of Medicinal Chemistry | 2000 |
Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy
JA Mitchell, TD Warner |
British Journal of Pharmacology | 1999 |
Glucocorticoids Augment Fibroblast-Mediated Contraction of Collagen Gels by Inhibition of Endogenous PGE Production
CM Sköld, XD Liu, YK Zhu, T Umino, K Takigawa, Y Ohkuni, RF Ertl, JR Spurzem, DJ Romberger, R Brattsand, SI Rennard |
Proceedings of The Association of American Physicians | 1999 |
Ex vivoassay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs
F Giuliano, TD Warner |
British Journal of Pharmacology | 1999 |
COX-2 and Alzheimer’s disease: potential roles in inflammation and neurodegeneration
MK O’Banion |
Expert Opinion on Investigational Drugs | 1999 |
4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)
JJ Talley, SR Bertenshaw, DL Brown, JS Carter, MJ Graneto, CM Koboldt, JL Masferrer, BH Norman, DJ Rogier, BS Zweifel, K Seibert |
Medicinal Research Reviews | 1999 |
Regulation of prostaglandin production in carrageenan-induced pleurisy melatonin
S Cuzzocrea, G Costantino, E Mazzon, AP Caputi |
Journal of Pineal Research | 1999 |
COX-1 und COX-2: Funktionen und pharmakologische Beeinflussung
B Hinz, K Brune |
Pharmazie in unserer Zeit | 1999 |
COX-2 inhibitors
CJ Hawkey |
The Lancet | 1999 |
Suppression of inducible cyclooxygenase 2 gene transcription by aspirin and sodium salicylate
XM Xu, L Sansores-Garcia, XM Chen, N Matijevic-Aleksic, M Du, KK Wu |
Proceedings of the National Academy of Sciences | 1999 |
THE USE OF ANALGESICS IN THE MANAGEMENT OF PAIN IN RHEUMATIC DISEASES
LW Moreland, EW st. Clair |
Rheumatic Disease Clinics of North America | 1999 |
SELECTIVE CYCLOOXYGENASE-2 INHIBITORS
BD Golden, SB Abramson |
Rheumatic Disease Clinics of North America | 1999 |
Management of inflammatory pain with selective COX-2 inhibitors: Promises and facts
PF Bejarano |
Current Pain and Headache Reports | 1999 |
Restricted cyclooxygenase-2 expression in the central nervous system following acute and delayed-type hypersensitivity responses to bacillus Calmette-Guérin
L Minghetti, P Hughes, VH Perry |
Neuroscience | 1999 |
Nouveaux anti-inflammatoires non stéroïdiens: donneurs de NO et inhibiteurs sélectifs de COX-2
B Bannwarth, F Berenbaum |
La Revue de Médecine Interne | 1999 |
Newer Analgesics
PM Taylor |
Veterinary Clinics of North America Small Animal Practice | 1999 |
The effect of selective cyclooxygenase-2 inhibitor on corneal angiogenesis in the rat
M Yamada, M Kawai, Y Kawai, Y Mashima |
Current Eye Research | 1999 |
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2
P Brooks, P Emery, JF Evans, H Fenner, CJ Hawkey, C Patrono, J Smolen, F Breedveld, R Day, M Dougados, EW Ehrich, J Gijon-Baños, TK Kvien, MH van Rijswijk, T Warner, H Zeidler |
Rheumatology (Oxford, England) | 1999 |
Non-steroidal anti-inflammatory drugs: back to the future
RJ Flower |
Rheumatology (Oxford, England) | 1999 |
Inducible Enzymes in the Inflammatory Response
DA Willoughby, A Tomlinson |
1999 | |
The action mechanism of cyclooxygenase-2 inhibitor for treatment of experimental allergic neuritis
K Miyamoto, N Oka, T Kawasaki, H Satoi, A Matsuo, I Akiguchi |
Muscle & Nerve | 1999 |
Prophylaxis and Treatment of NSAID-Induced Gastroduodenal Disorders:
RL Corte, M Caselli, G Castellino, G Bajocchi, F Trotta |
Drug Safety | 1999 |
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2.
McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Lawson JA, FitzGerald GA |
Proceedings of the National Academy of Sciences | 1999 |
Neue nichtsteroidale Antirheumatika: Selektive Hemmstoffe der induzierbaren Cyclooxygenase
DO Stichtenoth, H Zeidler, JC Frölich |
Medizinische Klinik | 1998 |
Effects of inhibitors of the activity of cyclo-oxygenase-2 on the hypotension and multiple organ dysfunction caused by endotoxin: A comparison with dexamethasone
M Leach, LC Hamilton, A Olbrich, GM Wray, C Thiemermann |
British Journal of Pharmacology | 1998 |
Effects of compounds extracted from Santolina oblongifolia on TXB2 release in human platelets
AM Silván, MJ Abad, P Bermejo, A Villar |
Inflammopharmacology | 1998 |
The potential application of cyclo-oxygenase type 2 inhibitors to Alzheimer’s disease
TA Sandson, O Felician |
Expert Opinion on Investigational Drugs | 1998 |
Recently reported inhibitors of cyclooxygenase-2
JS Carter |
Expert Opinion on Therapeutic Patents | 1998 |
Localisation of prostaglandin endoperoxide H synthase (PGHS)-1 and PGHS-2 in bone following mechanical loading in vivo
MR Forwood, WL Kelly, NF Worth |
The Anatomical Record | 1998 |
Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice
H Matsumoto, H Naraba, A Ueno, T Fujiyoshi, M Murakami, I Kudo, S Oh-ishi |
European Journal of Pharmacology | 1998 |
Mechanism of Action of Nonsteroidal Anti-inflammatory Drugs
TL Yaksh, DM Dirig, AB Malmberg |
Cancer Investigation | 1998 |
Topical glucocorticoids and the skin--mechanisms of action: an update
A Ahluwalia |
Mediators of Inflammation | 1998 |
Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes
WJ Lukiw, RP Pelaez, J Martinez, NG Bazan |
Proceedings of the National Academy of Sciences | 1998 |
The advent of highly selective inhibitors of cyclooxygenase—a review
B Cryer, A Duboisø |
Prostaglandins & Other Lipid Mediators | 1998 |
Pharmacodynamics and pharmacokinetics of tolfenamicacid in ruminating calves: Evaluation in models of acute inflammation
P Lees, QA McKellar, R Foot, G Gettinby |
The Veterinary Journal | 1998 |
Principles of Medical Biology
JO Jørgensen |
Principles of Medical Biology | 1998 |
Advances in Protein Chemistry
CM Silva, J Isgaard, MO Thorner |
Advances in Protein Chemistry | 1998 |
Termination of Acute-Phase Response
A Koj |
General Pharmacology: The Vascular System | 1998 |
Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1 -induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes
WJ Lukiw, RP Pelaez, J Martinez, NG Bazan |
Proceedings of the National Academy of Sciences | 1998 |
Synthesis and pharmacological evaluation of new flosulide analogues, synthesized from natural safrole
AS Lages, KC Silva, AL Miranda, CA Fraga, EJ Barreiro |
Bioorganic & Medicinal Chemistry Letters | 1998 |
Effects of lysine clonixinate on cyclooxygenase I and II in rat lung and stomach preparations
AM Franchi, GD Girolamo, AR los Santos, ML Martí, MA Gimeno |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1998 |
Selective COX-2 Inhibitors
J Vane, J Botting |
1998 | |
Mechanism of action of aspirin-like drugs
JR Vane, RM Botting |
Seminars in Arthritis and Rheumatism | 1997 |
A classification of NSAIDs according to the relative inhibition of cyclooxygenase isoenzymes
JC Frölich |
Trends in Pharmacological Sciences | 1997 |
Nitric oxide synthase and cyclo-oxygenase pathways in the inflammatory response induced by zymosan in the rat air pouch
M PayÁ, PG PASTOR, J Coloma, MJ ALCARAZ |
British Journal of Pharmacology | 1997 |
Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases
W Neupert, R Brugger, C Euchenhofer, K Brune, G Geisslinger |
British Journal of Pharmacology | 1997 |
Expression of recombinant human cyclooxygenase isoenzymes in transfected COS-7 cells in vitro and inhibition by tenoxicam, indomethacin and aspirin
M Lora, S Morisset, HA Ménard, R Leduc, AJ Brum-Fernandes |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1997 |
Cyclooxygenase-2 inhibitors: A new approach to the therapy of ocular inflammation
JL Masferrer, PS Kulkarni |
Survey of Ophthalmology | 1997 |
Staphylococcal exoproducts down-regulate cyclooxygenase 1 and 2 in peritoneal macrophages
RK Mackenzie, N Topley, A Neubauer, GA Coles, JD Williams |
Journal of Laboratory and Clinical Medicine | 1997 |
Tomoxiprole Selectively Inhibits Cyclooxygenase-2
RE West, SM Williams, HS She, NI Carruthers, RW Egan, MM Billah |
Prostaglandins | 1997 |
Effect of spinal cyclooxygenase inhibitors in rat using the formalin test and in vitro prostaglandin E2 release
DM Dirig, GP Konin, PC Isakson, TL Yaksh |
European Journal of Pharmacology | 1997 |
Effects of dexamethasone administration to diestrus cows on systemic progesterone, estrogen and uterine cyclooxygenase production
JR Broussard, A Rocha, J Sirois, JD Roussel, JK Thibodeaux, RA Godke, W Hansel |
Animal Reproduction Science | 1997 |
Tumour necrosis factor-α induces cyclo-oxygenase-2 gene expression in first trimester trophoblasts: suppression by glucocorticoids and NSAIDs
HM Imseis, PD Zimmerman, P Samuels, DA Kniss |
Placenta | 1997 |
Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages
L Pang, JR Hoult |
Biochemical Pharmacology | 1997 |
Macrophage-induced nitric oxide and prostanoid dependent relaxation of arterial smooth muscles
H Wang, R Mizuno, T Ohhashi |
Canadian Journal of Physiology and Pharmacology | 1997 |
HDL-Induced Prostacyclin Release in Smooth Muscle Cells Is Dependent on Cyclooxygenase-2 (Cox-2)
M Viñals, J Martínez-González, JJ Badimon, L Badimon |
Arteriosclerosis, thrombosis, and vascular biology | 1997 |
Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research
H Sinzinger, B Samuelsson, JR Vane, R Paoletti, P Ramwell, PY Wong |
1997 | |
Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury 2
KV Honn, S Nigam, LJ Marnett |
1997 | |
Side Effects of Anti-Inflammatory Drugs IV
KD Rainsford |
1997 | |
Iontophoresis of Dexamethasone in the Treatment of Endotoxin-Induced-Uveitis in Rats
FF Behar-Cohen, JM Parel, Y Pouliquen, B Thillaye-Goldenberg, OL Goureau, S Heydolph, Y Courtois, YD Kozak |
Experimental Eye Research | 1997 |
Cyclooxygenase-1 and Cyclooxygenase-2 in the Human Optic Nerve Head
AH Neufeld, M Hernandez, M Gonzalez, A Geller |
Experimental Eye Research | 1997 |
Cyclo-Oxygenase Isoenzymes: How Recent Findings Affect Thinking About Nonsteroidal Anti-Inflammatory Drugs
JY Jouzeau, B Terlain, A Abid, E Nédélec, P Netter |
Drugs | 1997 |
Tenidap, a structurally novel drug for the treatment of arthritis: Antiinflammatory and analgesic properties
PF Moore, DL Larson, IG Otterness, A Weissman, SB Kadin, FJ Sweeney, JD Eskra, A Nagahisa, M Sakakibara, TJ Carty |
Inflammation Research | 1996 |
Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications
M Pairet, G Engelhardt |
Fundamental & Clinical Pharmacology | 1996 |
Prostaglandin synthase 2
H Herschman |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1996 |
Meloxican: Influence on arachidonic acid metabolism Part 1. In vitro findings
G Engelhardt |
Biochemical Pharmacology | 1996 |
Induction of cyclooxygenase and nitric oxide synthase in endotoxin-activated J774 macrophages is differentially regulated by indomethacin: Enhanced cyclooxygenase-2 protein expression but reduction of inducible nitric oxide synthase
L Pang, JR Hoult |
European Journal of Pharmacology | 1996 |
Differential inhibition of cyclooxygenase-1 (COX-1) and-2 (COX-2) by NSAIDS: Consequences on anti-inflammatory activity versus gastric and renal safety
M Pairet, L Churchill, G Trummlitz, G Engelhardt |
Inflammopharmacology | 1996 |
Inducible cyclo-oxygenase (COX-2) mediates the induction of bone formation by mechanical loading in vivo
MR Forwood |
Journal of Bone and Mineral Research | 1996 |
Mechanism of Action of Anti-Inflammatory Drugs
JR Vane, RM Botting |
Scandinavian Journal of Rheumatology | 1996 |
Effect of Bakuchiol on Leukocyte Functions and Some Inflammatory Responses in Mice
ML Ferrándiz, B Gil, MJ Sanz, A Ubeda, S Erazo, E González, R Negrete, S Pacheco, M Payáa, MJ Alcaraz |
Journal of Pharmacy and Pharmacology | 1996 |
Pharmacological manipulation of cyclo-oxygenase-2 in the inflamed hydronephrotic kidney
K Seibert, JL Masferrer, P Needleman, D Salvemini |
British Journal of Pharmacology | 1996 |
Down-regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes
E Porreca, M Reale, CD Febbo, MD Gioacchino, RC Barbacane, ML Castellani, G Baccante, P Conti, F Cuccurullo |
Immunology | 1996 |
Interaction between nitric oxide and cyclooxygenase pathways
MD Rosa, A Ialenti, A Ianaro, L Sautebin |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1996 |
CYCLOOXYGENASE-2 INHIBITORS
JL Masferrer, PC Isakson, K Seibert |
Gastroenterology Clinics of North America | 1996 |
Advances in Lipobiology
PJ Trotter, DR Voelker |
Advances in Lipobiology | 1996 |
Meloxican: Influence on arachidonic acid metabolism
G Engelhardt, R Bögel, C Schnitzler, R Utzmann |
Biochemical Pharmacology | 1996 |
A Single Amino Acid Difference between Cyclooxygenase-1 (COX-1) and −2 (COX-2) Reverses the Selectivity of COX-2 Specific Inhibitors
JK Gierse, JJ McDonald, SD Hauser, SH Rangwala, CM Koboldt, K Seibert |
The Journal of biological chemistry | 1996 |
Myocardial Ischemia: Mechanisms, Reperfusion, Protection
M Karmazyn |
1996 | |
Improved Non-Steroid Anti-Inflammatory Drugs: COX-2 Enzyme Inhibitors
J Vane, J Botting, R Botting |
1996 | |
Analgetika Antinozizeptiva Adjuvanzien
HH Waldvogel |
1996 | |
New Targets in Inflammation
N Bazan, J Botting, J Vane |
1996 | |
Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors
D Salvemini, PT Manning, BS Zweifel, K Seibert, J Connor, MG Currie, P Needleman, JL Masferrer |
Journal of Clinical Investigation | 1995 |
Regulation of prostaglandin H synthase 2 expression in human monocytes by the marine natural products manoalide and scalaradial Novel effects independent of inhibition of lipid mediator production
K Glaser |
Biochemical Pharmacology | 1995 |
Inflammation, reproduction, cancer and all that?. The regulation and role of the inducible prostaglandin synthase
HR Herschman, W Xie, S Reddy |
BioEssays | 1995 |
Eicosanoid production and levels of newly characterized eicosanoid-forming enzymes in glomeruli and tubules of rat kidneys
H YANAGISAWA, J MORRISSEY, N KURIHARA, O WADA, S KLAHR |
Nephrology | 1995 |
Cyclooxygenase selectivity and NSAIDs: Cyclooxygenase-2 selectivity of etodolac (LODINE)
KB Glaser |
Inflammopharmacology | 1995 |
Regulation of prostaglandin production by nitric oxide; an in vivo analysis
D Salvemini, SL Settle, JL Masferrer, K Seibert, MG Currie, P Needleman |
British Journal of Pharmacology | 1995 |
Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase
JK Gierse, SD Hauser, DP Creely, C Koboldt, SH Rangwala, PC Isakson, K Seibert |
Biochemical Journal | 1995 |
Modulation by nitric oxide of prostaglandin biosynthesis in the rat
L Sautebin, A Ialenti, A Ianaro, MD Rosa |
British Journal of Pharmacology | 1995 |
Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression
M Goppelt-Struebe |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1995 |
Discordance between macrophage arachidonate metabolic phenotype and the expression of cytosolic phospholipase A2 and cyclooxygenase
GJ Dolecki, M Rogers, JB Lefkowith |
Prostaglandins | 1995 |
Pharmacodynamic profile of prostacyclin
JR Vane, RM Botting |
The American Journal of Cardiology | 1995 |
Signal sorting by G-protein-linked receptors
G Milligan |
Advances in pharmacology (San Diego, Calif.) | 1995 |
Diclofenac and prednisolone inhibit endotoxin-induced uveitis in rabbits
PS Kulkarni, CA Paterson |
Experimental Eye Research | 1995 |
Prostaglandin E2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774
S Milano, F Arcoleo, M Dieli, R D'Agostino, P D'Agostino, GD Nucci, E Cillari |
Prostaglandins | 1995 |
New insights into the mode of action of anti-inflammatory drugs
JR Vane, RM Botting |
Inflammation Research | 1995 |
Novel Molecular Approaches to Anti-Inflammatory Therapy
W Pruzanski, P Vadas |
1995 | |
Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids
LJ Crofford, RL Wilder, AP Ristimäki, H Sano, EF Remmers, HR Epps, T Hla |
Journal of Clinical Investigation | 1994 |
Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation
D Salvemini, K Seibert, JL Masferrer, TP Misko, MG Currie, P Needleman |
Journal of Clinical Investigation | 1994 |
On Radiation Damage to Normal Tissues and its Treatment: II. Anti-inflammatory drugs
AS Michalowski |
Acta Oncologica | 1994 |
Induction of cyclooxygenase ii in human synovial microvessel endothelial cells by interleukin-1
A Szczepanski, T Moatter, WW Carley, ME Gerritsen |
Arthritis & Rheumatism | 1994 |
Regulation of prostaglandin synthase-1 and prostaglandin synthase-2
HR Herschman, W Hall |
Cancer and Metastasis Reviews | 1994 |
Dietary protein restriction in isolated glomeruli from rats with bilateral ureteral obstruction
H Yanagisawa, N Kurihara, S Klahr, J Morrissey, O Wada |
Kidney International | 1994 |
Cytokine Regulation of Eicosanoid Generation
P Isakson, S Hauser, Y Zhang, K Leahy, J Masferrer, K Seibert |
Annals of the New York Academy of Sciences | 1994 |
Induction of cyclo-oxygenase-2 by cytokines in human pulmonary epithelial cells: regulation by dexamethasone
JA Mitchell, MG Belvisi, P Akarasereenont, RA Robbins, OJ Kwon, J Croxtall, PJ Barnes, JR Vane |
British Journal of Pharmacology | 1994 |
Thromboxane A2 receptor blocking abrogates donor-specific unresponsiveness to renal allografts induced by thymic recognition of major histocompatibility allopeptides
G Remuzzi, M Noris, A Benigni, O Imberti, MH Sayegh, N Perico |
Journal of Experimental Medicine | 1994 |
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
JL Masferrer, BS Zweifel, PT Manning, SD Hauser, KM Leahy, WG Smith, PC Isakson, K Seibert |
Proceedings of the National Academy of Sciences | 1994 |
Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
K Seibert, Y Zhang, K Leahy, S Hauser, J Masferrer, W Perkins, L Lee, P Isakson |
Proceedings of the National Academy of Sciences | 1994 |
Regional haemodynamic responses to acetylcholine, methoxamine, salbutamol and bradykinin during lipopolysaccharide infusion in conscious rats
J Waller, SM Gardiner, T Bennett |
British Journal of Pharmacology | 1994 |
The mechanism of the inhibitory effect of polyamines on the induction of nitric oxide synthase: role of aldehyde metabolites
C Szabó, GJ Southan, C Thiemermann, JR Vane |
British Journal of Pharmacology | 1994 |
Annexins: the problem of assessing the biological role for a gene family of multifunctional calcium- and phospholipid-binding proteins
P Raynal, HB Pollard |
Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes | 1994 |
Lipid Mediators
JR Vane, RM Botting |
Lipid Mediators | 1994 |
Lipocortin-derived peptides
M Perretti |
Biochemical Pharmacology | 1994 |
Ligand-induced prostaglandin synthesis requires expression of the TIS10/PGS-2 prostaglandin synthase gene in murine fibroblasts and macrophages
ST Reddy, HR Herschman |
The Journal of biological chemistry | 1994 |
Glucocorticoids as cytokine inhibitors: role in neuroendocrine control and therapy of inflammatory diseases
G Fantuzzi, P Ghezzi |
Mediators of Inflammation | 1993 |
Nitric oxide activates cyclooxygenase enzymes
D Salvemini, TP Misko, JL Masferrer, K Seibert, MG Currie, P Needleman |
Proceedings of the National Academy of Sciences | 1993 |
Prednisolone stimulates hepatic glutathione synthesis in mice
RF Speck, C Schranz, BH Lauterburg |
Journal of Hepatology | 1993 |
Immunopharmacology of the Gastrointestinal System
L Parente, KG Mugridge |
Immunopharmacology of the Gastrointestinal System | 1993 |
Exaggerated splanchnic PGI2 release following acute hemorrhage is due to new protein synthesis
SI Myers, R Hernandez |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1993 |
Amplification of the Arachidonic Acid Cascade: Implications for Pharmacologic Intervention
NR Baird, AR Morrison |
American Journal of Kidney Diseases | 1993 |
The Molecular Basis of Eicosanoid Action
EA Meagher, GA Fitzgerald |
Hypertension in Pregnancy | 1993 |
Pathophysiology of Shock, Sepsis, and Organ Failure
G Schlag, H Redl |
1993 | |
Macrophages and Related Cells
MA Horton |
1993 | |
Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells
CC Pilbeam, H Kawaguchi, Y Hakeda, O Voznesensky, CB Alander, LG Raisz |
The Journal of biological chemistry | 1993 |
In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis
H Sano, T Hla, JA Maier, LJ Crofford, JP Case, T Maciag, RL Wilder |
Journal of Clinical Investigation | 1992 |
Methylprednisolone dosage effects on peripheral lymphocyte subpopulations and eicosanoid synthesis
S Rota, A Rambaldi, F Gaspari, M Noris, E Daina, A Benigni, A Perna, R Donadelli, G Remuzzi, S Garattini |
Kidney International | 1992 |
Evidence that endogenous interleukin-1 is involved in leukocyte migration in acute experimental inflammation in rats and mice
M Perretti, E Solito, L Parente |
Agents and Actions | 1992 |
Regulation of cyclooxygenase and thromboxane synthase in human monocytes
R NUSING, V ULLRICH |
European Journal of Biochemistry | 1992 |
Enhancement of prostaglandin E2 production by liver macrophages (Kupffer cells) after stimulation with biological response modifiers
N Kawada, Y Mizoguchi, K Kobayashi, T Monna, P Liu, S Morisawa |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1992 |
Cytokines and eicosanoids in cancer drug toxicity
P Preziosi, L Parente, P Navarra |
Trends in Pharmacological Sciences | 1992 |
Distribution and characterization of cyclooxygenase immunoreactivity in the ovine brain
CD Breder, WL Smith, A Raz, J Masferrer, K Seibert, P Needleman, CB Saper |
The Journal of Comparative Neurology | 1992 |
Effects of Steroids and Immunosuppressive Drugs on Endotoxin-Uveitis in Rabbits
EO Ohia, M Mancino, PS Kulkarni |
Journal of Ocular Pharmacology and Therapeutics | 1992 |
Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme
JL Masferrer, K Seibert, B Zweifel, P Needleman |
Proceedings of the National Academy of Sciences | 1992 |
Human cyclooxygenase-2 cDNA
T Hla, K Neilson |
Proceedings of the National Academy of Sciences | 1992 |
cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase
MK O'Banion, VD Winn, DA Young |
Proceedings of the National Academy of Sciences | 1992 |
The role of nitric oxide in endothelial cell damage and its inhibition by glucocorticoids
RM Palmer, L Bridge, NA Foxwell, S Moncada |
British Journal of Pharmacology | 1992 |
Glucocorticoids and prostaglandin synthesis: We cannot see the wood for the trees
D Duval, M Freyss-Beguin |
Prostaglandins, Leukotrienes and Essential Fatty Acids | 1992 |
Prostaglandin endoperoxide synthase gene structure: Identification of the transcriptional start site and 5′-flanking regulatory sequences
SA Kraemer, EA Meade, DL DeWitt |
Archives of Biochemistry and Biophysics | 1992 |
Mammalian lipoxygenases: molecular structures and functions
S Yamamoto |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1992 |
The Organic Chemistry of Drug Design and Drug Action
RB Silverman |
The Organic Chemistry of Drug Design and Drug Action | 1992 |
Manipulation of thromboxane synthesis by novel 26,27-dialkyl analogues of 1α,25-dihydroxyvitamin D3 in human promyelocytic leukemia (HL-60) cells
A Honda, Y Mori, N Ikekawa, A Raz |
European Journal of Pharmacology | 1992 |
Protein increases glomerular eicosanoid production and activity of related enzymes
H Yanagisawa, J Morrissey, J Yates, C Hayes, S Klahr |
Kidney International | 1992 |
Possible induction of fatty acid cyclo-oxygenase in lipopolysaccharide-stimulated rat Kupffer cells
N Kawada, Y Mizoguchi, K Kobayashi, T Monna, S Morisawa, N Ueda, Y Omoto, Y Takahashi, S Yamamoto |
Gastroenterology | 1992 |
Diethylcarbamazine inhibits endothelial and microfilarial prostanoid metabolism in vitro
N Kanesa-thasan, JG Douglas, JW Kazura |
Molecular and Biochemical Parasitology | 1991 |
Endotoxin-induced arachidonic acid metabolism requires de novo protein synthesis and protein kinase C activation
J Geisel, JA Cook, KA Coffee, WC Wise, PV Halushka |
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism | 1991 |
Prostaglandins, Leukotrienes, Lipoxins, and PAF
JM Bailey |
1991 | |
A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein
MK O'Banion, HB Sadowski, V Winn, DA Young |
The Journal of biological chemistry | 1991 |
Cyclooxygenase gene expression is down-regulated by heparin-binding (acidic fibroblast) growth factor-1 in human endothelial cells
T Hla, T Maciag |
The Journal of biological chemistry | 1991 |
Progress in Medicinal Chemistry
JR Brown, SH Imam |
Progress in Medicinal Chemistry | 1985 |
Progress in Nucleic Acid Research and Molecular Biology
FS Collins, SM Weissman |
Progress in nucleic acid research and molecular biology | 1984 |
The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs
GD Anderson, SD Hauser, KL McGarity, ME Bremer, PC Isakson, SA Gregory |
Journal of Clinical Investigation | 1981 |
The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs
GD Anderson, SD Hauser, KL McGarity, ME Bremer, PC Isakson, SA Gregory |
Journal of Clinical Investigation | 1981 |
Alteration of canine renal vascular response to hemorrhage by inhibitors of prostaglandin synthesis
BF McAdam, F Catella-Lawson, IA Mardini, S Kapoor, JA Lawson, GA FitzGerald |
The American journal of physiology | 1976 |
Alteration of canine renal vascular response to hemorrhage by inhibitors of prostaglandin synthesis
BF McAdam, F Catella-Lawson, IA Mardini, S Kapoor, JA Lawson, GA FitzGerald |
The American journal of physiology | 1976 |